Interview with Jacques Neefjes in the Guardian: One man's mission to revive a forgotten, life-saving cancer drug
Dutch immunologist Jacques Neefjes believes the drug aclarubicin, unavailable in Europe for 20 years, could have helped 100,000 people with a rare blood cancer.